• No results found

[PDF] Top 20 Oxybutynin topical gel in the treatment of overactive bladder

Has 10000 "Oxybutynin topical gel in the treatment of overactive bladder" found on our website. Below are the top 20 most common "Oxybutynin topical gel in the treatment of overactive bladder".

Oxybutynin topical gel in the treatment of overactive bladder

Oxybutynin topical gel in the treatment of overactive bladder

... of oxybutynin that was specifically designed to minimize anticholinergic effects and application site skin ...than oxybutynin TDS, the previously developed transdermal patch formulation of ... See full document

8

Treatment of overactive bladder in the aging population: focus on darifenacin

Treatment of overactive bladder in the aging population: focus on darifenacin

... the treatment of overactive bladder ...the treatment of overactive bladder syndrome is to block the parasympathetic acetylcholine pathway and thus abolish or reduce the intensity ... See full document

8

Role of fesoterodine in the treatment of overactive bladder

Role of fesoterodine in the treatment of overactive bladder

... for treatment of patients with overactive bladder ...the treatment of ...to bladder filling (decreasing micturition frequency and increasing mean voided volume) and urgency (urgency and ... See full document

9

Overactive bladder: the importance of tailoring treatment to the individual patient

Overactive bladder: the importance of tailoring treatment to the individual patient

... This short communication is a consensus opinion-based review highlighting the dis- cussions of an advisory board of renowned experts in the field of overactive bladder (OAB). These professionals, who are ... See full document

5

Update on tolterodine extended-release for treatment of overactive bladder

Update on tolterodine extended-release for treatment of overactive bladder

... Abstract: Overactive bladder is a prevalent condition which negatively impacts quality of life and puts a significant economical burden on ...the treatment of overactive ...life, ... See full document

7

OnabotulinumtoxinA for the treatment of overactive bladder

OnabotulinumtoxinA for the treatment of overactive bladder

... effective treatment for adults with refractory overactive ...second-line treatment to patients who have failed behavioral therapy and oral medications such as antimuscarinics and β3 ... See full document

11

Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: a prospective comparative study

Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: a prospective comparative study

... neurogenic bladder, urinary tract infection, bladder lithiasis, genital prolapse higher than stage II on the Pelvic Organ Prolapse Quantification system, uncontrolled narrow angle glaucoma, severe cardiac ... See full document

5

Fesoterodine for the treatment of urinary incontinence and overactive bladder

Fesoterodine for the treatment of urinary incontinence and overactive bladder

... Overactive bladder is a highly prevalent condition associated with significant impact on quality of life, associated morbidi- ties and ...the treatment of ...Only oxybutynin has shown ... See full document

8

Social, economic, and health utility considerations in the treatment of overactive bladder

Social, economic, and health utility considerations in the treatment of overactive bladder

... Abstract: Overactive bladder (OAB) is a highly prevalent urinary syndrome with a profound impact on quality of life (QoL) of affected patients and their family because of its adverse effects on social, ... See full document

14

Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root, in the treatment of symptoms of overactive bladder and urinary incontinence: a phase 2, randomised, double blind placebo controlled tri

Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root, in the treatment of symptoms of overactive bladder and urinary incontinence: a phase 2, randomised, double blind placebo controlled trial

... of bladder symptoms compared to an identical placebo, were documented in a randomised, double-blind, placebo controlled trial conducted at two primary care ... See full document

11

<p>Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient</p>

<p>Mirabegron in the Treatment of Overactive Bladder: Safety and Efficacy in the Very Elderly Patient</p>

... 50 mg; or placebo in a 2:2:1:1:1:1 ratio. Changes from base- line to end of treatment were reported at 12 weeks. The combination of solifenacin 5mg and mirabegron 50mg was superior to solifenacin 5mg in terms of ... See full document

7

Overactive bladder: strategies to ensure treatment compliance and adherence

Overactive bladder: strategies to ensure treatment compliance and adherence

... ER, oxybutynin chloride ER, and three times-daily oxybutynin ...taking oxybutynin IR and 44% of those tak- ing either once-daily drug remained adherent for longer than 30 ...for oxybutynin ER ... See full document

6

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin

Real life persistence rate with antimuscarinic treatment in patients with idiopathic or neurogenic overactive bladder: a prospective cohort study with solifenacin

... antimuscarinic treatment in pa- tients with neurogenic OAB has not been thoroughly ...evaluated. Treatment for neurogenic OAB is important in order to provide more bladder control, decrease urin- ary ... See full document

5

Profile of mirabegron in the treatment of overactive bladder: place in therapy

Profile of mirabegron in the treatment of overactive bladder: place in therapy

... of treatment in maximum urinary flow rate (Q max ) and detrusor pressure at Q max (PdetQ max ...the bladder contractility index and the bladder voiding efficiency after 12 weeks of treatment, ... See full document

5

Overactive bladder in children

Overactive bladder in children

... Propiverine for OAB treatment is neither approved for adults nor children in Canada and the U.S. (approaval under evaluation), but it is available in Europe and Asia in IR and ER formulas (23 countries). Its ... See full document

6

Oxybutynin extended release for the management of overactive bladder: a clinical review

Oxybutynin extended release for the management of overactive bladder: a clinical review

... Abstract: Overactive bladder (OAB) is a common condition which negatively impacts the quality of life of afflicted ...of treatment include both behavioral therapy and pharmacotherapy. ... See full document

11

Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin

Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin

... Abstract: Overactive bladder syndrome (OAB) is a constellation of distressing symptoms that signifi cantly impair quality of life, sexual function, and work productivity, and imposes a signifi cant economic ... See full document

8

Concepts in the Management of the Overactive Bladder in Women

Concepts in the Management of the Overactive Bladder in Women

... The overactive bladder is a common age related dysfunction of the bladder wall and reduced bladder capacity combined with hyper-excitability of detrusor muscles cause urgency and ...therapy, ... See full document

6

Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder

Clinical utility of transdermal delivery of oxybutynin gel via a metered-dose pump in the management of overactive bladder

... This new formulation, whether administered by sachet or pump, is an interesting therapeutic option for the man- agement of a common and distressing problem that will become more common as the proportion of older people ... See full document

8

NGF and HB EGF: Potential Biomarkers that Reflect the Effects of Fesoterodine in Patients with Overactive Bladder Syndrome

NGF and HB EGF: Potential Biomarkers that Reflect the Effects of Fesoterodine in Patients with Overactive Bladder Syndrome

... awaken in the morning?”, “How often do you have a sudden desire to urinate, which is difficult to defer?”, and “How of- ten do you leak urine because you cannot defer your sud- den urge to urinate?” were lower than their ... See full document

8

Show all 10000 documents...